For platforms & brands
License the layer. Don't build it.
Telehealth, supplement & CPG, botanical-extraction, and EHR/clinical-software teams field the “what about a natural option?” question at scale — and answering it carries real claim risk. Embed Myto's mechanism graph and claim-safe response layer instead of carrying that risk yourself.
Why license it
Platforms can't build this safely. So they license it.
Answering the plant-vs-medication question at scale means owning the claim-safety risk that comes with it — the language, the citations, the evidence grading, the disclaimers. That's a regulatory surface most teams can't safely build. Myto is the mechanism layer you embed instead: claim-safe by construction, cited to the source, with shares mechanism framing — never alternative to.
Telehealth
Answer the botanical question inside the visit, without putting a claim in a clinician's mouth.
Supplement & CPG
Educate buyers around your line in mechanism language that stays inside the compliance line.
Clinical software
The botanical layer your EHR / decision-support stack doesn't have — graded, cited, ready to surface.
What you embed
A structured, evidence-graded mechanism graph.
Every medication mapped to the botanicals that share a molecular target — drug → target → compound → plant, with the metabolic (CYP/P-gp) overlap axis and a claim-safe reason on every edge. Citations resolve to a specific PubMed ID on the large majority of records. It's structured infrastructure, not a search box.
Early access
We're onboarding design partners now.
If your product fields the natural-option question, let's talk about an early-access integration. We'll walk you through the data layer and the claim-safe response template live.
Myto Intelligence is an educational reference layer. It teaches, compares, and cites; it does not diagnose, treat, or recommend, and it is not a substitute for professional medical judgment.